Niger vs Zambia: Population requiring preventive chemotherapy for schistosomiasis
Niger
5.10 million
in 2024
Zambia
4.79 million
in 2024
Niger rank
16th
Zambia rank
17th
Population requiring preventive chemotherapy for schistosomiasis over time
- Niger
- Zambia
How they compare
Niger currently reports 5.10 million against 4.79 million in Zambia, a difference of 306,020.
That makes Niger's figure about 1.1 times Zambia's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Niger ahead.
Niger ranks 16th and Zambia ranks 17th of 52 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.02 million | 4.65 million | 368,874 | Niger |
| 2020s | 8.69 million | 4.50 million | 4.19 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Niger or Zambia?
- Niger, at 5.10 million against 4.79 million in Zambia as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Niger and Zambia?
- 306,020, with Niger ahead.
- How many years of comparable data are there for Niger and Zambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Niger and Zambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Niger ranks 16th and Zambia ranks 17th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.